Flu Relief Therapy Nighttime

Product NDC
15127-922
11-digit product format
151270922
Labeler code
15127
Product ID
15127-922_dd01353c-5083-47c7-bace-ff3ed4fff9fe
Type
HUMAN OTC DRUG
Nonproprietary name
Acetaminophen, Diphenhydramine HCl, Phenylephrine HCl
Dosage form
LIQUID
Route
ORAL
Labeler
Select Brand Dist.
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2011-12-28
Marketing end
2021-12-30
Substance
ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
Active strength
650 mg/30mL; mg/30mL; mg/30mL
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct15127-922DDiscontinued by firm2026-11-19
excluded packagepackage15127-92215127-922-08DDiscontinued by firm2026-11-19

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage15127-922-08d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage15127-922-08f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage15127-922-082ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage15127-922-08a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage15127-922-08cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage15127-922-08cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage15127-922-08302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage15127-922-08ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage15127-922-080efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage15127-922-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage15127-922-08367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage15127-922-08557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
DIPHENHYDRAMINE HYDROCHLORIDEACTIVE INGREDIENTTC2D6JAD40FLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
PHENYLEPHRINE HYDROCHLORIDEACTIVE INGREDIENT04JA59TNSJFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
ACETAMINOPHENACTIVE MOIETY362O9ITL9DFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
DIPHENHYDRAMINEACTIVE MOIETY8GTS82S83MFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
PHENYLEPHRINEACTIVE MOIETY1WS297W6MVFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
ACESULFAME POTASSIUMINACTIVE INGREDIENT23OV73Q5G9FLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
ALCOHOLINACTIVE INGREDIENT3K9958V90MFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSLFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86KFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOAFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
GLYCERININACTIVE INGREDIENTPDC6A3C0OXFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
MALTITOLINACTIVE INGREDIENTD65DG142WKFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3FLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
TRISODIUM CITRATE DIHYDRATEINACTIVE INGREDIENTB22547B95KFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2
WATERINACTIVE INGREDIENT059QF0KO0RFLU RELIEF THERAPY NIGHTTIME SEVERE COLD (ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL) LIQUID [SELECT BRAND DIST.]2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
15127-922-0815127092208245 mL in 1 BOTTLE, PLASTIC (15127-922-08) 245 ml2011-12-282021-12-30NoNoCurrent